Suchergebnisse - "Immunologic Factors"

PubPharm (2.850)

1

Progress in novel delivery technologies to improve efficacy of therapeutic antibodies

enthalten in: Antiviral research | 2024

von Sun, W. | Wu, Y. | Ying, T.

2

Use of immunomodulators in combination with infliximab in Crohn's disease : time for a reappraisal?

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Chapman, T. | Ahmad, T. | Satsangi, J.

3

enthalten in: Aktuelle Urologie | 2024

4

Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy : a pooled analysis of European prospective observational studie

enthalten in: Clinical and experimental rheumatology | 2024

von Govoni, M. | Batalov, A. | Boumpas, D. | +6

5

Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients : a systematic review and meta-analysis

enthalten in: Acta neurologica Belgica | 2024

von Rabea, E. | Belal, M. | Hafez, A. | +5

6

Managing acute COVID-19 in immunocompromised pediatric patients

enthalten in: Expert review of clinical immunology | 2024

von Mercolini, F. | Abram, N. | Cesaro, S.

7

Small-molecule modulators of tumor immune microenvironment

enthalten in: Bioorganic chemistry | 2024

von Zhang, J. | Yu, J. | Liu, M. | +7

8

Development of a therapeutic monoclonal antibody against circulating adipocyte fatty acid binding protein to treat ischaemic stroke

enthalten in: British journal of pharmacology | 2024

von Liao, B. | Yang, S. | Geng, L. | +8

9

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC : A Phase 2 Randomized Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Vokes, E. | Mornex, F. | Sezer, A. | +17

10

Immunomodulator combination versus mono therapy : Does combination therapy have an impact on infliximab therapy?

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Yuksel, I. | Cagir, Y. | Atay, A.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[285]